{"GHMDC classification":["Diagnosis"],"GHMDC health topic":["HIV/AIDS"],"GHMDC manufacturer coordinates":["42.378877777778, -72.032366666667"],"GHMDC manufacturer location":["Massachusetts, United States"],"GHMDC scope":["Commercialized"],"Page SDG":["SDG09 Industry innovation and infrastructure","SDG03 Good health and well-being"],"Page URL":["https://www.appropedia.org/Global_Health_Medical_Device_Compendium/PointCare_NOW_Machine"],"Page affiliations":["Appropedia Foundation","University of Michigan"],"Page authors":["User:Lonny","User:Chriswaterguy","User:Emilio","Kathleen Sienko","Amir Sabet Sarvestani"],"Page description":["For people living with HIV, the presence of the virus can be detected through a CD4 cells, which are cells that fight infection. In general as HIV progresses, CD4 cells go down which is indicative of a weakening immune system. For HIV-infected patients, a CD4 count should be administered before anti-retroviral therapies begin. However, modern technology for CD4 counting is not easily accessible throughout the developing world. Current technology, such as the flow-cytometry CD4 counter, range from US$30,000–$150,000 which is beyond the affordability for health systems with financial constraints."],"Page image":["File:Pointcare now.png"],"Page language":["en"],"Page license":["CC-BY-SA-3.0"],"Page parent":["Global Health Medical Device Compendium"],"Page root":["Global Health Medical Device Compendium"],"Page title":["Global Health Medical Device Compendium/PointCare NOW Machine"],"Page views":[337],"Page year":["Sunday, 01-Jan-12 00:00:00 UTC"],"Modification date":["Thursday, 10-Sep-26 14:09:31 UTC"]}